XML 30 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
6. Stockholders equity (Tables)
3 Months Ended
Sep. 30, 2012
Equity [Abstract]  
Warrrants outstanding
Shares Outstanding     Weighted Average Exercise Price     Shares Vested   Expiration Fiscal Period
  2,805,600     $ 1.45       2,805,600   4th Qtr, 2013
  40,000       0.01       40,000   3rd Qtr, 2014
  200,000       1.25       200,000   4th Qtr, 2014
  108,500       0.24       108,500   1st Qtr, 2015
  30,000       0.53       30,000   4th Qtr, 2016
  50,000       0.50       50,000   1st Qtr, 2017
  1,079,000       0.55       677,640   4th Qtr, 2021
  125,000       0.53       -   1st Qtr, 2022
  35,000       0.53       -   2nd Qtr, 2022
  1,462       3.25       1,462   3rd Qtr, 2022
  52,000       0.75       -   1st Qtr, 2023
  4,526,562               3,913,202    
Weighted average assumptions for Black-Scholes-Merton option pricing formula
Expected life (in years) 4.35 years
Weighted average volatility 135.89%
Forfeiture rate 20.00 %
Risk-free interest rate 1.22%
Expected dividend rate - %
Exercise prices for options and warrants granted and outstanding which resulted in stock based compensation charges
Exercise Price Range   Number of options or warrants
$0.25 - $0.50   50,000
$0.51 – $0.75   1,297,000
$0.76 - $1.00   -
$1.01 - $1.25   624,000
$1.26 - $2.00   32,500
$2.01 - $3.00   -
$3.01 - $4.00   1,462
    2,004,962
Summary of non-vested options and warrants
    Shares  
Non-vested outstanding, July 1, 2012     624,173  
Granted     102,000  
Vested     (112,813 )
Cancelled     -  
Non-vested outstanding, September 30, 2012     613,360  
Shares of common stock reserved for future issuance
Stock options outstanding     1,133,462  
Stock options available for future grant under the 2011 Plan     366,538  
Warrants     3,393,100  
         
Total common shares reserved for future issuance     4,893,100